PHP
NVST icon

Parkman Healthcare Partners’s Envista NVST Stock Holding History

Parkman Healthcare Partners’s Portfolio NVST Stock Details NVST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Sell
553,916
-157,777
-22% -$3.98M 1.49% 27
2026
Q1 		$18.1M Buy
+711,693
New +$18.5M 1.86% 17

Other funds holding NVST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Parkman Healthcare Partners's NVST Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Envista (NVST) stake by 22% in Q2 2026, selling an estimated $3.98M and leaving 553,916 shares worth $14.6M. The position accounts for 1.49% of the portfolio, ranked #27.

Parkman Healthcare Partners first reported a position in NVST in Q1 2026 and has held it in 2 quarters since. The position peaked at $18.1M in Q1 2026. 382 funds tracked by Wall St. Rank hold NVST as of Q2 2026.

  • Parkman Healthcare Partners held 553,916 shares of Envista worth $14.6M as of Q2 2026.
  • Parkman Healthcare Partners sold 157,777 Envista shares in Q2 2026, an estimated $3.98M.
  • Envista made up 1.49% of Parkman Healthcare Partners's portfolio in Q2 2026, its #27 holding.
  • Parkman Healthcare Partners first reported a position in Envista in Q1 2026 and has held it in 2 quarters since.
  • Parkman Healthcare Partners's Envista position peaked at $18.1M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held Envista as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.